Anterix director sells 10,100 shares near $87
Anterix director Leslie B. Daniels disclosed open-market sales totaling 10,100 ATEX shares over two days, with remaining indirect holdings via retirement accounts.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Anterix Inc. (ATEX) director Leslie B. Daniels reported selling a total of 10,100 shares of Anterix common stock in open-market transactions on September 3–4, 2026. Reported prices included $87.15, $87.3103 and $86.50 per share, with some prices stated as weighted averages over intraday ranges.
After these transactions, Daniels was reported as holding 2,000 shares indirectly through an IRA and 5,000 shares indirectly through a 401(k) plan as of September 3, 2026. No Rule 10b5-1 trading plan was reported for these sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2 | 2,900 | $87.3103 | $253K |
| Sale | Common Stock | 1,200 | $86.50 | $104K |
| Sale | Common Stock F1 | 6,000 | $87.15 | $523K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.30 to $87.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $87.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
Key Figures
Key Terms
weighted average price financial
IRA financial
401K financial
indirectly financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Anterix (ATEX) director Leslie B. Daniels report?
What were the price ranges for the weighted-average sales reported by the Anterix (ATEX) director?
Does the Anterix (ATEX) Form 4 indicate use of a Rule 10b5-1 trading plan?
What Anterix (ATEX) holdings does Leslie B. Daniels report after these transactions?
Were the Anterix (ATEX) insider sales executed in the open market or privately?
AI-generated analysis. How Rhea-AI works. Not financial advice.